Our novel tetra-specific T cell engager targeting CD33 x CD123 x CD70 x CD3
CUSTOM-BUILT BIOLOGY FOR PATIENTS
We are pioneering DARPin therapeutics to go beyond the limits of today’s leading treatments
Learn more >>We are pioneering DARPin therapeutics to go beyond the limits of today’s leading treatments
Learn more >>We are pioneering DARPin therapeutics to go beyond the limits of today’s leading treatments
Learn more >>We are deeply motivated to deliver unique therapies to people with cancer and other serious diseases.
Hear what drives us to go the extra mile.
We are in urgent need of new medicines for all those with cancer — including many we know personally. This thought keeps me motivated to give my best.
I am inspired by how an idea within a university lab has been transformed into a publicly-listed company with the opportunity to make a meaningful impact in patients’ lives.
I joined Molecular Partners to find an interesting job – and I stayed for the passion to build something meaningful!
I’m inspired on a daily basis by Molecular Partners’ high-quality science, my driven colleagues, and our potential impact on the lives of cancer patients.
My favorite part about Molecular Partners is working together within a team of specialists and seeing the direct impact of my daily work on the development of drugs.
The Molecular Partners team is unique because we share a common vision and combine our diverse experiences and skill sets to achieve our goals.